1. Home
  2. APGE vs PLUS Comparison

APGE vs PLUS Comparison

Compare APGE & PLUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • PLUS
  • Stock Information
  • Founded
  • APGE 2022
  • PLUS 1990
  • Country
  • APGE United States
  • PLUS United States
  • Employees
  • APGE N/A
  • PLUS N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • PLUS Retail: Computer Software & Peripheral Equipment
  • Sector
  • APGE Health Care
  • PLUS Technology
  • Exchange
  • APGE Nasdaq
  • PLUS Nasdaq
  • Market Cap
  • APGE 2.6B
  • PLUS 1.9B
  • IPO Year
  • APGE 2023
  • PLUS 1996
  • Fundamental
  • Price
  • APGE $37.61
  • PLUS $67.12
  • Analyst Decision
  • APGE Strong Buy
  • PLUS
  • Analyst Count
  • APGE 4
  • PLUS 0
  • Target Price
  • APGE $97.50
  • PLUS N/A
  • AVG Volume (30 Days)
  • APGE 1.2M
  • PLUS 138.7K
  • Earning Date
  • APGE 08-11-2025
  • PLUS 08-12-2025
  • Dividend Yield
  • APGE N/A
  • PLUS N/A
  • EPS Growth
  • APGE N/A
  • PLUS N/A
  • EPS
  • APGE N/A
  • PLUS 4.05
  • Revenue
  • APGE N/A
  • PLUS $2,068,789,000.00
  • Revenue This Year
  • APGE N/A
  • PLUS $3.30
  • Revenue Next Year
  • APGE $743.14
  • PLUS $2.29
  • P/E Ratio
  • APGE N/A
  • PLUS $16.56
  • Revenue Growth
  • APGE N/A
  • PLUS N/A
  • 52 Week Low
  • APGE $26.20
  • PLUS $53.83
  • 52 Week High
  • APGE $63.50
  • PLUS $106.98
  • Technical
  • Relative Strength Index (RSI)
  • APGE 42.46
  • PLUS 41.82
  • Support Level
  • APGE $37.05
  • PLUS $66.15
  • Resistance Level
  • APGE $42.29
  • PLUS $69.70
  • Average True Range (ATR)
  • APGE 1.78
  • PLUS 1.74
  • MACD
  • APGE -0.13
  • PLUS -0.18
  • Stochastic Oscillator
  • APGE 14.44
  • PLUS 18.83

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About PLUS ePlus inc.

ePlus Inc is a provider of technology solutions across the IT spectrum, spanning security, cloud, data center, networking, collaboration, AI, service provider, and critical infrastructure, and emerging solutions, to domestic and foreign organizations across all industry segments. Its solutions leverage a broad range of professional, consultative, and managed services across the technology spectrum. The company possesses top-level engineering certifications with a broad range of IT technologies that enable the company to offer multi-vendor IT solutions that are optimized for each of its customers' specific requirements. It also offers a wide portfolio of technology and other capital asset financing solutions to customers across commercial and government enterprises, designing programs.

Share on Social Networks: